In a normal week, central bank policy meetings in the US and UK would dominate the headlines, but given elevated geopolitical risks, it does not feel like a normal week.

Financial markets continue to display confidence that the trade war remains on a de-escalating path, even as the deadline for ‘trade deals’ to be agreed with the US moves into focus.

Although a drive to onshore manufacturing of pharmaceuticals is admirable, there could be some unintended consequences around price, availability and global relations.